Skip to content

Assessment of Renal Physiology by Magnetic Resonance Imaging (MRI) in Normal Volunteers

Assessment of Renal Physiology (Glomerular Filtration Rate and Blood Flow) by MRI With Validation by Inulin and Para-Aminohippuric Acid Clearance in Normal Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00936416
Enrollment
24
Registered
2009-07-10
Start date
2010-01-31
Completion date
2011-12-31
Last updated
2012-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glomerular Filtration Rate, Renal Blood Flow

Keywords

Glomerular Filtration Rate, Renal Blood Flow, MRI, Inulin, Para-Aminohippuric Acid

Brief summary

Estimation of Glomerular Filtration Rate (GFR) is the primary test used to assess patients with renal disease. Although serum creatinine based GFR and nuclear medicine based estimations are routinely used in clinical practice, GFR estimation by Inulin is the recommended gold standard. Inulin based estimation of GFR is cumbersome and time consuming. A decrease in blood flow to the kidney (Renal Blood Flow (RBF)) is known to cause a decrease in GFR. RBF is typically determined using radioactive tracers, contrast MRI or a cumbersome para-aminohippuric acid (PAH) clearance method. MRI based assessment of GFR and RBF have been suggested to provide reasonable accuracy. Most of these studies did not compare the GFR and RBF estimation directly to Inulin and PAH clearance which are ther gold standards . In this study we propose to estimate MRI based GFR estimation directly to Inulin and noncontrast MRI based derived RBF to PAH to assess if MRI is an accurate test of kidney function.

Interventions

PROCEDUREInulin and PAH clearance and MRI

GFR and renal blood flow estimation by Inulin and PAH clearance will be performed in the Renal Physiology Lab for approximately 2.5 hours; The MRI test will be performed afterwards at Medical Imaging department and last about 45 minutes.

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male or female volunteers with no known renal disease * Ages between 18-65 years * Normal routine urinalysis * Estimated GFR (eGFR) \>=90mls/min * Arterial pressure \< 130/85 * No medications (birth control pills and vitamins are acceptable)

Exclusion criteria

* Pregnancy * Age \<18y or \>65y * Proteinuria or hematuria as determined by routine urinalysis * Estimate GFR (eGFR) \< 90 ml/min * Known history or requirement of treatment for hypertension * Known allergy to inulin or PAH * MRI contrast allergy, general contraindications to MRI such as pacemaker, etc.

Design outcomes

Primary

MeasureTime frame
GFR estimation comparison between results obtained by MRI and Inulin clearance method. Blood flow estimation comparison between results obtained by MRI and PAH clearance method.1 year

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026